Tirzepatide for renal insufficiency, chronic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Sep 2022: Trial registered, NCT05536804
  2. 8 Feb 2023: Trial started, NCT05536804

The trials

NCT05536804: A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

State
Completed
Phase
Phase 2
People
134 taking part
Started
8 Feb 2023
Primary completion
6 Jul 2026
Arms
Tirzepatide
Results
None posted
  1. 13 Sep 2022: Trial registered
  2. 8 Feb 2023: Trial started
  3. 30 Jul 2026: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Arm 5- Tirzepatide, Mounjaro, Tirzepatide (LIPOLESS de Laboratorio de Productos Eticos C.E.I.S.A.), Zepbound.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.